Back to Business
Business
7 August 2026
Why Halozyme, An IBD 50 Stock, Just Hit A Record High In Bullish Volume
Halozyme stock rocketed to a record high Friday as its newer Enhanze-tied products starting driving incremental growth.
About this report
Downunder Voices provides an independently written summary and community perspective based on information published by the original source. The original publisher remains responsible for its reporting.
Join our community
Follow Downunder Voices
Join thousands of readers following news and community stories from Australia, New Zealand and the Pacific.
